Shared Decision Making to Address Racial Disparities in Oral Anticoagulation in NVAF

Part of paid clinical trials in Durham, North Carolina.

Sponsor
Duke University
Study ID
NCT04956978
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • Patient Decision Support Tool — OTHER
    Patient decision support tool is a web based educational material that informs a patient on the risk and benefits of oral anticoagulation. In addition, such a tool aims to assess patient values and preferences in the decision making process for oral anticoagulation for stroke reduction.

Study Details

The study is a pilot analysis using a decision on the risk and benefits of oral anticoagulation for stroke reduction for patients with non-valvular atrial fibrillation. This study is a feasibility and acceptability analysis but will also measure preliminary effectiveness measures. The investigator hypothesizes that a patient decision support tool will increase decision quality and secondarily increase the use of oral anticoagulation in Black patients with non-valvular atrial fibrillation.

Key Dates

Start date
Jun 1, 2026
Status verified
Aug 2025
Primary completion
Dec 31, 2026
Completion
Dec 31, 2026

Study Design

Enrollment
40 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Patient Decision Support Tool
    Patient decision support tool to be used in conjunction with physician counseling to discuss the risk and benefits of systemic oral anticoagulation.
  • No Intervention: Usual Healthcare Counseling
    Traditional physician counseling regarding the risk and benefits of systemic oral anticoagulation

Primary Outcome Measure

Proportion of patients willing to consent as measured by enrollment log [ Time Frame: End of Study, 12 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Duke University Medical CenterDurhamNorth Carolina27710
Larry Jackson

Find similar trials in Durham, NC

By condition
Atrial fibrillation
By specialty
CardiologyHeart disease
By research site
Duke University Medical Center· Durham, NC

Related Studies